UK To Diverge On Biosimilar Data Requirements

But EU Off-Patent Industry Prefers Global Approach

 
• By Ian Schofield
  
GUIDANCE CONCEPT
The MHRA is to issue new guidance on biosimilars • Source: Shutterstock

More from United Kingdom

More from Europe